NCT06334757 2024-03-28
Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure
Henan Cancer Hospital
Phase 2 Unknown
Clinical Trials
7 trialsNCT06208033 2024-01-17
SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT02737774 2020-07-01
Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation
Henan Cancer Hospital
Phase 2 Unknown
NCT03790228 2020-04-15
Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC
Henan Cancer Hospital
Phase 1 Unknown
NCT03566576 2018-06-25
Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel
Fujian Cancer Hospital
Phase NA Unknown
NCT03376737 2017-12-18
Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma
Henan Cancer Hospital
Phase 2 Unknown
NCT02804646 2016-06-21
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
Anhui Provincial Hospital
Phase 4 Unknown